Can a common arthritis drug make PKU treatment safer and more effective?
NCT ID NCT07477691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding methotrexate (a drug that calms the immune system) can help adults with PKU tolerate and respond better to Palynziq, a protein-based treatment. About 12 adults who either haven't taken Palynziq before or have high blood Phe levels despite treatment will receive both drugs for 6 months. The goal is to see if methotrexate reduces immune reactions that can limit Palynziq's effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60611, United States
-
Children's Hospital Colorado
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
-
Children's Hospital of Wisconsin
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Indiana University School of Medicine
NOT_YET_RECRUITINGIndianapolis, Indiana, 46202, United States
-
Oregon Health & Science University (OHSU) - PARENT
NOT_YET_RECRUITINGPortland, Oregon, 97239, United States
-
UCLA Dept. of Human Genetics
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
-
University Of South Florida Medical Center
NOT_YET_RECRUITINGTampa, Florida, 33613, United States
-
University of Minnesota Medical School
NOT_YET_RECRUITINGMinneapolis, Minnesota, 55455, United States
-
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Rochester Medical Center (URMC)
NOT_YET_RECRUITINGRochester, New York, 14642, United States
-
University of Utah Hospital
NOT_YET_RECRUITINGSalt Lake City, Utah, 84108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study aims to tailor PKU drug dosing for patients with organ impairment
- Hidden eating disorders may affect PKU patients on strict diets
- New pill could tame phenylketonuria by blocking amino acid absorption
- PKU diagnosis: a study on breaking the news to families
- New pill for PKU shows promise in early human testing
- Camp curriculum aims to boost pregnancy outcomes in rare metabolic disorders